Patent details

EP2564872 Title: Mazindol alone or in combination with iron for the treatment of attention-deficit/hyperactivity disorder

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2564872
WO Application Number:
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP12189703.7
WO Publication Number:
EPO Publication Language:
French
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:

Dates

Filing date:
11/04/2007
Grant date:
10/06/2020
EP Publication Date:
06/03/2013
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
02/09/2020
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
10/06/2020
EP B1 Publication Date:
10/06/2020
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
02/09/2020
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
10/04/2027
Lapsed By Expiration Date:
Patent Validated Date:
08/09/2020
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
17/11/2020
 
 

 

Name:
NLS Pharmaceutics AG
Address:
Alter Postplatz 2, 6370, Stans, Switzerland (CH)

Historical Applicant/holder

From:
10/06/2020
To:
17/11/2020

 

Name:
NLS-1 Pharma AG
Address:
Alter Postplatz 2, 6370 Stans, Switzerland (CH)

Agent

Name:
ir. F.A. Geurts c.s.
From:
04/09/2020
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Inventor

Name:
Konofal, Eric
Address:
60300 Senlis, France (FR)

Priority

Priority Patent Number:
0603197
Priority Date:
11/04/2006
Priority Country:
France (FR)

Classification

IPC or IDT classification:
A61K 31/4188; A61K 33/26; A61P 25/26;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
50/20
Publication date:
09/12/2020
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
EP3
Journal edition number:
37/20
Publication date:
09/09/2020
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
24/20
Publication date:
10/06/2020
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
202024
Publication date:
10/06/2020
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC202002271A
Date Registered:
17/11/2020
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
NLS Pharmaceutics AG
Address:
Alter Postplatz 2, 6370, Stans, Switzerland (CH)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
30/04/2024
Grace Period End Date:
31/10/2024
Annual Fee Number:
18
Annual Fee Amount:
1200 Euro
Penalty Fee Amount:
600 Euro
Last Annual Payment Date:
27/03/2023
Last Annual Fee Paid Number:
17
Last Annual Fee Paid Amount:
1100 Euro
Payer:
Acumass
Filing date Document type Document Description Number of pages File Type
07/09/2020 Outgoing Correspondence Letter no formal defects 1 PDF /4/4/6/3/6/0800563644/docs/ep12189703.7_0_365202l271.pdf
02/09/2020 Claims First filed claims 2 PDF /4/4/6/3/6/0800563644/docs/ep12189703.7_1_claims20200902164515081.pdf
02/09/2020 Description First filed description 15 PDF /4/4/6/3/6/0800563644/docs/ep12189703.7_2_description20200902164515436.pdf